- Home
- AMS vs BOLT Comparison
AMS vs BOLT Comparison
Compare AMS & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMS | BOLT |
|---|---|---|
| Founded | 1980 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.8M | 10.5M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AMS | BOLT |
|---|---|---|
| Price | $2.10 | $4.12 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $34.00 |
| AVG Volume (30 Days) | 6.8K | ★ 24.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 230.00 | 9.84 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $19,714,000.00 | $7,690,000.00 |
| Revenue This Year | $3.81 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.81 | N/A |
| 52 Week Low | $2.02 | $0.26 |
| 52 Week High | $3.11 | $7.35 |
Technical Indicators
Market Signals| Indicator | AMS | BOLT |
|---|---|---|
| Relative Strength Index (RSI) | 45.26 | 32.55 |
| Support Level | $2.04 | $0.28 |
| Resistance Level | $2.19 | $5.45 |
| Average True Range (ATR) | 0.06 | 0.41 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 27.75 | 7.91 |
Price Performance
Historical ComparisonAbout AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.